| Embryonal Neoplasm studied in …STUDIED_INderived200 of 1,126show all (up to 200) |
|---|
| → studied in | NCT04616560Phase 2 · recruiting Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04724369Phase 3 · completed Open-Label Study of 18F-mFBG for Imaging Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06479811Phase 1 · recruiting [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers · condition mapped ALIAS · 1,126 trials mapped (349 active) | — | — | Olfactory Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07005297not yet recruiting Clinical Genetics Branch Eligibility Screening Survey · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Chordoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07492316Phase 1 · active not recruiting RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB) · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01109394recruiting Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01247597recruiting DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Pleuropulmonary Blastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01445288completed Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors · condition mapped ALIAS · 1,126 trials mapped (349 active) | — | — | Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07346157Phase 1/Phase 2 · recruiting Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06441331Phase 1 · recruiting Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07194044Phase 1 · recruiting Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07297979Phase 1 · recruiting Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02040376Phase 3 · completed Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma · condition mapped ALIAS · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04868799completed Finding New Targets by Proteomic Approaches (InnovRT1) · condition mapped ALIAS · 1,126 trials mapped (349 active) | — | — | Atypical Teratoid/Rhabdoid Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05230758Phase 3 · recruiting Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Childhood Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172296Phase 3 · recruiting Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ganglioneuroblastoma, Nodular | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06995872Phase 1 · recruiting Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04837547Phase 1 · active not recruiting PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06926283Phase 1 · recruiting A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07830134NA · recruiting Cognitive Rehabilitation for Survivors of Childhood Medulloblastoma Using Real Time Hemodynamic Neurofeedback · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Childhood Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01005654recruiting Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01857934Phase 2 · completed Therapy for Children With Advanced Stage Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Childhood Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03251989completed Rare CNS Tumors Outcomes &Risk · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped ALIAS · 1,126 trials mapped (349 active) | — | — | Olfactory Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07830667Phase 1/Phase 2 · not yet recruiting A Phase 1/2 Study of CBX-12 in Children, Adolescents, or Young Adults With Solid Tumors That Have Come Back After Treatment or Are Difficult to Treat · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Childhood Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07833631completed A Prospective Image Reevaluation Study to Assess the Efficacy of 18F-mFBG PET Imaging in Subjects With Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698994Phase 2 · active not recruiting Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06176989Phase 2 · recruiting Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Olfactory Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06804655Phase 2 · recruiting Pharmacoscopy for Patients With Refractory Primary Brain Tumors · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05421897Phase 2 · active not recruiting Rapid Administration Pilot for Infusing Dinutuximab · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06395103Phase 1/Phase 2 · recruiting Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07537400Phase 2 · recruiting Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5 · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07695311Phase 1 · not yet recruiting EWSR1 Immunotherapy in Ewing Sarcoma and DSRCT · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04211675Phase 1/Phase 2 · active not recruiting NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06858501Phase 2 · withdrawn Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05535166Phase 2 · recruiting Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819838Phase 1/Phase 2 · not yet recruiting Testing the Addition of an Anti-Cancer Drug, Daraxonrasib, for Relapsed or Refractory Solid Tumors With RAS Mutations · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Childhood Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03533582Phase 3 · active not recruiting Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06674811recruiting Biomarkers of Resiliency In Childhood Cancer Surgery · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06639607Phase 1/Phase 2 · suspended PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07087002Phase 1 · recruiting GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05027386Phase 1/Phase 2 · completed Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study. · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07437963Phase 1/Phase 2 · not yet recruiting Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07809178not yet recruiting China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Chordoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03715933Phase 1 · recruiting Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01711554Phase 1 · active not recruiting Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02559778Phase 2 · recruiting Pediatric Precision Laboratory Advanced Neuroblastoma Therapy · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03911388Phase 1 · recruiting HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors · condition mapped ALIAS · 1,126 trials mapped (349 active) | — | — | Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05041127Phase 2 · active not recruiting Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Chordoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02679144Phase 2 · active not recruiting Neuroblastoma Maintenance Therapy Trial · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04301843Phase 2 · active not recruiting Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06156410Phase 1 · recruiting Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06465199Phase 1/Phase 2 · recruiting Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Atypical Teratoid/Rhabdoid Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06540963Phase 2 · recruiting Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541262Phase 1/Phase 2 · recruiting Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06959979early Phase 1 · recruiting Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Childhood Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07358260Phase 1 · recruiting B7-H3.CD28Z.CART in Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07390539Phase 1 · recruiting B7-H3.CD28Z.CART in CNS Neoplasms · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05918640Phase 1/Phase 2 · recruiting Lurbinectedin in FET-Fused Tumors · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01875601Phase 1 · completed NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02114229Phase 2 · active not recruiting Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors · condition mapped PROBABILISTIC · 1,126 trials mapped (349 active) | — | — | Rhabdoid Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04637503Phase 1/Phase 2 · not yet recruiting 4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07242963recruiting Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03793166Phase 3 · active not recruiting Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Rhabdoid Tumor of the Kidney | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02867592Phase 2 · active not recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06528496Phase 2 · recruiting N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03910465recruiting Children and Adults With Chordoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Chordoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03356782Phase 1/Phase 2 · not yet recruiting Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04433221Phase 1/Phase 2 · not yet recruiting Combination Immunotherapy Targeting Sarcomas · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06701812Phase 2 · recruiting Digoxin Medulloblastoma Study · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02176967Phase 3 · active not recruiting Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02402244recruiting Project: Every Child for Younger Patients With Cancer · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Congenital Mesoblastic Nephroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03126916Phase 3 · recruiting Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04322318Phase 2 · recruiting A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Anaplastic Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04851119Phase 1/Phase 2 · recruiting Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05382338Phase 3 · recruiting A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Childhood Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06401330Phase 3 · recruiting A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT) · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Mixed Cell Type Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06647953Phase 3 · recruiting Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Pleuropulmonary Blastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05096481Phase 2 · recruiting PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07635056Phase 2 · recruiting Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781891Phase 2 · not yet recruiting RAPID: Phase 2 Platform Trial Of Promising Drugs For AYA Patients With R/R Ewing Sarcoma & DSRCT · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01946529Phase 2 · completed Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04106219Phase 1 · active not recruiting A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05395741Phase 1/Phase 2 · completed Regorafenib in Patients With Refractory Primary Bone Tumors · condition mapped ALIAS · 1,126 trials mapped (349 active) | — | — | Bone Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05701306Phase 1/Phase 2 · recruiting APG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05968768Phase 2 · recruiting To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly) · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06820957Phase 2/Phase 3 · active not recruiting Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07261241Phase 2 · not yet recruiting NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07514819NA · recruiting Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07767630early Phase 1 · recruiting Safety, Tolerability, and Preliminary Efficacy of [211At]MABG in Patients With Relapsed or Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02112617NA · active not recruiting Phase II Study of Proton Radiation Therapy for Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02282735active not recruiting Parental Decision-Making for Children With Relapsed Neuroblastoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00918320Phase 2 · completed Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07660458withdrawn Parental Distress and Treatment Adherence in Pediatric Recurrent Medulloblastoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02243605Phase 2 · active not recruiting Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03173950Phase 2 · terminated Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00407433Phase 2 · completed Clinical Studies of Gemcitabine-Oxaliplatin · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04755205recruiting A Natural History Study of Children and Adults With Olfactory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Olfactory Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05650749Phase 1 · enrolling by invitation GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01326104Phase 2 · completed Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03389802Phase 1 · completed Phase I Study of APX005M in Pediatric Central Nervous System Tumors · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07136701recruiting Risk Factors, Prognosis, Clinicopathological and Metabolic Characteristics of EO- vs LO-PanNETs · condition mapped ALIAS · 1,126 trials mapped (349 active) | — | — | Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07172958Phase 1 · recruiting Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04696029Phase 2 · recruiting DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05489887Phase 2 · recruiting Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06161519Phase 1/Phase 2 · recruiting PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07527169Phase 2 · not yet recruiting A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Olfactory Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04936529Phase 2 · recruiting A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05057702NA · recruiting Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05642455Phase 1/Phase 2 · recruiting SPEARHEAD-3 Pediatric Study · condition mapped ALIAS · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03959800recruiting Molecular Basis of Pediatric Liver Cancer · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04947501early Phase 1 · active not recruiting A Study of N9 Chemotherapy in Children With Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03015844available A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04715191Phase 1 · recruiting Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00911560Phase 1/Phase 2 · completed Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral β-glucan for High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04539366Phase 1 · suspended Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Childhood Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06622941Phase 2 · recruiting Study to ONO-4538 in Patients With Rhabdoid Tumor · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Rhabdoid Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06822842completed Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04099797Phase 1 · recruiting C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B) · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Embryonal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04320888Phase 2 · active not recruiting Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06624371Phase 1 · recruiting Atovaquone Combined With Radiation in Children With Malignant Brain Tumors · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07628634early Phase 1 · recruiting Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03363373Phase 2 · active not recruiting Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03598244Phase 1 · active not recruiting Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04337177Phase 1 · active not recruiting Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02306161Phase 3 · active not recruiting Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04743661Phase 2 · active not recruiting 131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06057948Phase 2 · recruiting A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00379340Phase 3 · completed Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03155620Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05592743approved for marketing Vorasidenib Expanded Access Program · condition mapped ALIAS · 1,126 trials mapped (349 active) | — | — | Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07725783recruiting Prospective Evaluation of Dynamic Serum ProGRP for Treatment Response Monitoring in Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01370330available 131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07703605not yet recruiting AI-Assisted MRI Molecular Subtyping in Pediatric Brain Tumors · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06721689Phase 1/Phase 2 · recruiting PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02389244Phase 2 · completed A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07211737Phase 1 · recruiting NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02359565Phase 1 · active not recruiting Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05278208Phase 1/Phase 2 · recruiting Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Embryonal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06450041Phase 2 · recruiting NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02724579Phase 2 · active not recruiting Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284774Phase 2 · active not recruiting Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05286801Phase 1/Phase 2 · active not recruiting Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Atypical Teratoid/Rhabdoid Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06942039early Phase 1 · recruiting Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Central Nervous System Embryonal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07027748Phase 1 · recruiting Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06796543NA · recruiting Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07698899Phase 1 · recruiting A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS) · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213652Phase 2 · active not recruiting Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07694622NA · not yet recruiting Targeting MYC in High-Risk Medulloblastoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00904241completed Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07321912Phase 2 · recruiting Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07688252Phase 1 · not yet recruiting Dinutuximab-beta and Chemotherapy in Newly Diagnosed High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03189706early Phase 1 · active not recruiting Study of Chemoimmunotherapy for High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03635632Phase 1 · active not recruiting C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04634357Phase 1/Phase 2 · recruiting ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05835687Phase 1 · active not recruiting Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Atypical Teratoid/Rhabdoid Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07085325recruiting CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07685405recruiting Identification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03874455no longer available Tazemetostat Expanded Access Program for Adults With Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Poorly Differentiated Chordoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195555Phase 2 · active not recruiting Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04416568Phase 2 · active not recruiting Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Rhabdoid Tumor of the Kidney | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07007117Phase 1 · active not recruiting PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00980460Phase 3 · completed Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | PRETEXT I Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04751383Phase 1 · terminated Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06625190Phase 1/Phase 2 · recruiting Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04168788NA · completed Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06861244Phase 2 · recruiting Embryonal Tumor With Multilayered Rosettes · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Embryonal Tumor with Multilayered Rosettes | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07447076Phase 2 · recruiting Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT) · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Atypical Teratoid/Rhabdoid Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03299309Phase 1 · active not recruiting PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05130255Phase 1 · terminated GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06571734Phase 2 · recruiting XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00840047Phase 2 · active not recruiting Methionine PET/CT Studies In Patients With Cancer · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01346124NA · active not recruiting High Dose Intensity Modulated Proton Radiation Treatment +/- Surgical Resection of Sarcomas of the Spine, Sacrum and Base of Skull · condition mapped ALIAS · 1,126 trials mapped (349 active) | — | — | Spinal Chordoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Chordoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03050268recruiting Familial Investigations of Childhood Cancer Predisposition · condition mapped ALIAS · 1,126 trials mapped (349 active) | — | — | Hereditary Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213704Phase 2 · active not recruiting Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03541720early Phase 1 · active not recruiting 18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06193759Phase 1 · recruiting Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT) · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Childhood Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06104488Phase 1 · active not recruiting A Study of Avutometinib for People With Solid Tumor Cancers · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00496119Phase 2 · active not recruiting Proton Beam Therapy for Chordoma Patients · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Chordoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01192555Phase 1/Phase 2 · active not recruiting Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04500548Phase 1 · withdrawn Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085735Phase 3 · completed Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00392327Phase 3 · completed Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Anaplastic Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06607692Phase 1/Phase 2 · recruiting Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07188532NA · recruiting Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07318831Phase 2 · recruiting Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00352534Phase 3 · completed Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00945009Phase 3 · completed Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Adult Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02875314Phase 4 · active not recruiting HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03786783Phase 2 · completed Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04794686recruiting ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Embryonal Tumor with Multilayered Rosettes | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04978727Phase 1 · active not recruiting A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma · condition mapped CURATED_BROADER · 1,126 trials mapped (349 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07197554Phase 1 · recruiting A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07620431not yet recruiting Neoadjuvant Radiotherapy and Surgery for High-Risk Localized Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00107289Phase 2 · recruiting Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04559217Phase 2 · recruiting 68Ga-DOTATATE Neuroblastoma Imaging Pilot · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04087902active not recruiting Long-Term Longitudinal QoL in Patients Undergoing EEA · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Chordoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02311621Phase 1 · active not recruiting Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01 · condition mapped ONTOLOGY_EXACT · 1,126 trials mapped (349 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |